Lateral Epicondylitis Treatment Market

Date: 2016-05

Lateral epicondylitis is also commonly known as tennis elbow and is essentially the degeneration of the tendons attachment to the bone. The function of the tendon is to anchor the muscle to the bone and weakening of this can be quite painful. Lifting and gripping things becomes extremely painful in lateral epicondylitis. There are several reasons that result in the swelling of the elbow tendons and associated pain in the elbow joint. One of them includes the repetitive motion of swinging the forearm and elbow. Tennis players, swimmers, basketball players, golfers are some of people who tend to develop this condition. There are also certain professions such as plumbing, carpenters, and other heavy-duty professions that have witnessed a rise in tennis elbow. This is driving the growth of the lateral epicondylitis treatment market. The repeated use of the wrist by extending it against resistance is what basically causes this condition. In some cases, inappropriate use of weights in fitness centers can also cause lateral epicondylitis. Also, the geriatric population comprising adults over the age of 60 are also more prone to develop this condition owing to weakening of tendons. These factors are expected to further augment the growth of the lateral epicondylitis market. Some of the drugs currently under trials include botulinum toxin, topical nitrates and hyaluronate sodium.

One major hurdle that this market encounters is the slow development and commercialization of advanced therapies.

Lateral Epicondylitis Treatment Market

The market can be split into surgical and non-surgical lateral epicondylitis treatment methods and the non-surgical methods account for the larger share of the market.

The Lateral Epicondylitis Treatment market can be segmented on the basis of treatment as:
Extracorporeal Shock Wave Therapy
Medications and Physical therapies
North America and Europe hold the first and second positions respectively in terms of share of the overall lateral epicondylitis market. This can be attributed to the significantly larger geriatric population present in these regions. Higher awareness coupled with larger number of sports being played also adds to the growth of the market in those regions.

The market has been segmented based on the following geographies:
North America
South America
Middle East

Following are just a few of the companies that are operating in the Lateral Epicondylitis Treatment market:
Chugai Pharmaceutical
Kasiak Research
Moecular Phramacology Limited
Seikagaku Corporation
Teikoku Pharma


Contact With Us
Join templatemonster at google+
Customized Research
Request Sample